Prescription drug · NDA
Anticoagulant Sodium Citrate (trisodium citrate dihydrate) NDC 0338-9669
Trisodium citrate dihydrate 40 mg/mL · Solution · Extracorporeal · Baxter Healthcare Corporation
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0338-9669-01 | 00338966901 | 250 mL in 1 BAG (0338-9669-01)Marketed from Apr 2, 2024 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Anticoagulant Sodium Citrate
- Generic name (nonproprietary)
- trisodium citrate dihydrate
- Active ingredients
- Trisodium citrate dihydrate — 40 mg/mL
- Dosage form
- Solution
- Route
- Extracorporeal
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication BN 980123
- Marketing start
- Listing expires
- Other FDA classes
- Acidifying Activity (Mechanism)Calcium Chelating Activity (Mechanism)Decreased Coagulation Factor Activity (Physiologic effect)
- Identifiers
- Product ID 0338-9669_8855e600-2002-4c8b-94dc-d275de33169bSPL ID 8855e600-2002-4c8b-94dc-d275de33169bSPL set ID 7025a0f9-1a56-4416-a3a4-925d755aed90UNII B22547B95K
- Pharmacologic class
- Anti-coagulant; Calculi Dissolution Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N400338966901followed by a unit qualifier and the quantityPackage 00338-9669-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Anticoagulant Sodium Citrate 4% w/v Solution, USP is intended for use only with automated apheresis devices.
Excerpt only. Read the full label for complete information.